Glycoside Hydrolase Family 30

This page has been approved by the Responsible Curator as essentially complete. CAZypedia is a living document, so further improvement of this page is still possible. If you would like to suggest an addition or correction, please contact the page's Responsible Curator directly by e-mail.

• Author: Brian Rempel
• Responsible Curator: Stephen Withers

---

Glycoside Hydrolase Family 30
Clan	GH-A
Mechanism	retaining
Active site residues	known
CAZy DB link
http://www.cazy.org/fam/GH30.html

Substrate specificities

This family contains glycoside hydrolases with three known enzyme activities: β-glucosylceramidase, β-1,6-glucanase, and β-xylosidase. This family enzymes currently contains enzymes from only bacteria and eukaryotes. The best-studied enzyme is human β-glucocerebrosidase whose deficiency causes Gauchers disease [1]. This enzyme is responsible for hydrolyzing the β-glucoside from the glycolipid glucosylceramide.

Kinetics and Mechanism

Family GH30 enzymes are retaining enzymes. Although this has never been formally demonstrated experimentally through NMR analysis of the initially formed sugar product, covalent trapping of the enzymatic nucleophile (described below) conclusively demonstrates that these enzymes follow the classic Koshland double-displacement mechanism. The β-glucosylceramidases require an activator protein and negatively charged phospholipids for optimal activity, [2] although the role of these activators is still not entirely clear. Neither the β-1,6-glucanases [3] nor the β-xylosidases [4] appear to require any activators.

Catalytic Residues

The catalytic nucleophile was first identified in human β-glucocerebrosidase as Glu340 in the sequence FASEA by trapping of the 2-deoxy-2-fluoro-glucosyl-enzyme intermediate and subsequent peptide mapping by LC/MS-MS [5]. The catalytic nucleophile had been previously mistakenly identified as Asp443 using a tritiated bromoconduritol epoxide [6, 7], although subsequent kinetic analyses of site-directed mutants of Asp443 were not consistent with its role as the catalytic nucleophile [8]. The general acid/base residue of human β-glucoerebrosidase is predicted to be Glu-274 [9]. While this identification has not been experimentally verified through analysis of variant proteins created by mutation of that site, it is consistent with structural studies (below).

Three-dimensional structures

The three-dimensional structure of human β-glucocerebrosidase was first solved in 2003 [10], and since then several different structures of this enzyme have been reported (reviewed in [11]). GH30 enzymes are members of the GHA clan fold, consistent with the classic (α/β)₈ TIM barrel fold with the two key active site glutamic acids located at the C-terminal ends of β-strands 4 (acid/base) and 7 (nucleophile) [12].

Family Firsts

First catalytic nucleophile identification

Human β-glucocerebrosidase by 2-fluoroglucose labelling [1]

First 3-D structure of a GH30 enzyme

Human β-glucocerebrosidase [2]

References

1. Grabowski GA (2008). Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet. 2008;372(9645):1263-71. DOI:10.1016/S0140-6736(08)61522-6 |
2. Grabowski GA, Gatt S, and Horowitz M. (1990). Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease. Crit Rev Biochem Mol Biol. 1990;25(6):385-414. DOI:10.3109/10409239009090616 |
3. Oyama S, Yamagata Y, Abe K, and Nakajima T. (2002). Cloning and expression of an endo-1,6-beta-D-glucanase gene (neg1) from Neurospora crassa. Biosci Biotechnol Biochem. 2002;66(6):1378-81. DOI:10.1271/bbb.66.1378 |
4. Brunner F, Wirtz W, Rose JK, Darvill AG, Govers F, Scheel D, and Nürnberger T. (2002). A beta-glucosidase/xylosidase from the phytopathogenic oomycete, Phytophthora infestans. Phytochemistry. 2002;59(7):689-96. DOI:10.1016/s0031-9422(02)00045-6 |
5. Miao S, McCarter JD, Grace ME, Grabowski GA, Aebersold R, and Withers SG. (1994). Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry. J Biol Chem. 1994;269(15):10975-8. | Google Books | Open Library
6. Dinur T, Osiecki KM, Legler G, Gatt S, Desnick RJ, and Grabowski GA. (1986). Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site. Proc Natl Acad Sci U S A. 1986;83(6):1660-4. DOI:10.1073/pnas.83.6.1660 |
7. Legler G (1990). Glycoside hydrolases: mechanistic information from studies with reversible and irreversible inhibitors. Adv Carbohydr Chem Biochem. 1990;48:319-84. DOI:10.1016/s0065-2318(08)60034-7 |
8. Grace ME, Newman KM, Scheinker V, Berg-Fussman A, and Grabowski GA. (1994). Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression. J Biol Chem. 1994;269(3):2283-91. | Google Books | Open Library
9. Durand P, Lehn P, Callebaut I, Fabrega S, Henrissat B, and Mornon JP. (1997). Active-site motifs of lysosomal acid hydrolases: invariant features of clan GH-A glycosyl hydrolases deduced from hydrophobic cluster analysis. Glycobiology. 1997;7(2):277-84. DOI:10.1093/glycob/7.2.277 |
10. Dvir H, Harel M, McCarthy AA, Toker L, Silman I, Futerman AH, and Sussman JL. (2003). X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep. 2003;4(7):704-9. DOI:10.1038/sj.embor.embor873 |
11. Kacher Y, Brumshtein B, Boldin-Adamsky S, Toker L, Shainskaya A, Silman I, Sussman JL, and Futerman AH. (2008). Acid beta-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy. Biol Chem. 2008;389(11):1361-9. DOI:10.1515/BC.2008.163 |
12. Henrissat B, Callebaut I, Fabrega S, Lehn P, Mornon JP, and Davies G. (1995). Conserved catalytic machinery and the prediction of a common fold for several families of glycosyl hydrolases. Proc Natl Acad Sci U S A. 1995;92(15):7090-4. DOI:10.1073/pnas.92.15.7090 |